The medication reduces appetite and slows gastric emptying
All these years I have been taking oral, I did not realize you could also get it intravenously, and also, via spray and gel
Clinical trial data showed patients taking oral Wegovy lost an average of 13.6% of body weight at 71 weeks, while comparable injectable GLP-1 trials have shown average weight loss to be between 15% to 20%
The formulation aids in reducing the appearance of dark circles and acne scars for a smoother complexion
Gallbladder-related adverse events, including cholelithiasis and cholecystitis, have been reported with GLP-1 receptor agonist therapy
The takeaway: most people will not experience this side effect, and for non-diabetic patients, the overall risk is considered extremely low